Foamix Pharmaceuticals IPO Research Information

Foamix Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Foamix Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Foamix Pharmaceuticals	FOMX - NASDAQ	$10.00-$12.00	$6.00	$8.00	6.7 million	9/18/2014
Underwriter(s): Barclays, Cowen and Company
Co-Manager(s): Oppenheimer & Co., Maxim Group LLC
Industry: Health Care
Filing(s): Filed 2014-08-13 Terms Added 2014-09-03

Foamix Pharmaceuticals Quote & Chart - Click for current quote - FOMX

About Foamix Pharmaceuticals (adapted from Foamix Pharmaceuticals prospectus):
They are a clinical-stage specialty pharmaceutical company focused on developing and commercializing our proprietary minocycline foam for the treatment of acne, impetigo and other skin conditions.

This description is adapted from Foamix Pharmaceuticals prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as Foamix Pharmaceuticals "FOMX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.